GRAIL - Pioneering early-stage cancer testing using machine learning
Fill form to unlock content
Loading, please wait
Error - something went wrong!
Get Instant Access to On-Demand Content
Thank you!
GRAIL’s mission is to move from the screening for individual cancers to the screening of individuals for cancer. In this session, hear how GRAIL has developed the largest linked dataset of clinical genomics information, and how it leverages machine learning on AWS to both detect cancer signals, and identify the signal’s location in the body.